Background: While midterm outcomes after matrix-induced autologous chondrocyte implantation (MACI) are encouraging, the procedure permits an arthroscopic approach that may reduce the morbidity of arthrotomy and permit accelerated rehabilitation.
Matrix-induced autologous chondrocyte implantation (MACI) is a 2-stage surgical technique employed to address full-thickness, symptomatic knee chondral lesions. Initially, it involves a cartilage biopsy, isolation and expansion of chondrocytes ex vivo, seeding of cells directly onto a collagen membrane, and subsequent reimplantation into the knee. While encouraging clinical outcomes have been reported for MACI, 5, 12, 18, 19, 28, 41, 53 traditionally, second-stage implantation required open arthrotomy, although the surgical technique does permit an arthroscopic approach. Arthroscopic implantation reduces the associated morbidity of arthrotomy, including a reduced risk of complications such as adhesions, postoperative joint stiffness, excessive pain, and impressive scarring, 16 and may permit accelerated rehabilitation.
A number of arthroscopic techniques have now been proposed, with an array of associated technical difficulties and results reported.
{ To the best of our knowledge, there remain limited data investigating outcomes in patients after arthroscopically performed MACI to 5 years or beyond. 17, [28] [29] [30] In 2012, we presented outcomes in a pilot series of patients who underwent a new arthroscopic technique for performing MACI to determine the early safety and efficacy of this procedure in treating articular cartilage defects in the knee. 9 This study presents an extension of this patient cohort, with a comprehensive clinical and radiological follow-up in patients up to 5 years after surgery. We hypothesized that a significant improvement in clinical and radiological outcomes after this arthroscopic MACI technique would exist throughout the postoperative timeline to 5 years after surgery, with high levels of patient satisfaction.
METHODS

Participants
Between June 2006 and April 2010, 31 patients (15 male, 16 female) were prospectively recruited and evaluated before undergoing MACI via an arthroscopic surgical technique. Initially, an a priori power calculation was performed using G*Power (www.gpower.hhu.de/en.html) for the primary outcome variable: preoperative to postoperative change in the pain subscale of the Knee injury and Osteoarthritis Outcome Score (KOOS), demonstrating that 19 patients were required to reveal differences at the 5% significance level, with 90% power and employing a large effect size (0.8). Given the early success and steady flow of patients undergoing the arthroscopic surgical procedure, we continued recruitment to allow for attrition.
All patients exhibited persistent pain and symptoms associated with grade III or IV chondral lesions, assessed with the International Cartilage Repair Society (ICRS) chondral defect classification system. 6 Patients were candidates for MACI if they were 15 to 65 years of age; appeared able and willing to follow a structured rehabilitation program; and had isolated, full-thickness chondral defects. This was confirmed in all patients via a magnetic resonance imaging (MRI) assessment, which was also used to assess the location, size, and severity of the defect as well as other soft tissue damage incorporating the menisci or ligamentous structures. Patients were excluded if they had a body mass index (BMI) over 35 kg/m 2 , had ligamentous instability, had undergone prior extensive meniscectomy, had ongoing progressive inflammatory arthritis, or had varus/valgus lower limb malalignment (as indicated by .3°tibiofemoral anatomic angle). The orthopaedic specialist evaluated the patients for joint malalignment initially. Should further investigation be warranted, the patient would then be sent for Maquet views, although this was not required in any of these patients.
If the patient was suitable for MACI, the defect location and surrounding environment dictated whether he or she was a candidate for the arthroscopic approach. This was initially evaluated via MRI and confirmed at the time of first-stage arthroscopic biopsy. All patients over the time period who were planned for arthroscopic MACI based on the aforementioned criteria underwent the technique successfully. Isolated lesions on the weightbearing surface of the femoral or tibial condyle were considered, unless the lesion was at the external periphery of the condyle. These may be problematic with the arthroscopic technique because of the potential interference of the menisci with the inflatable portion of the indwelling catheter as per this arthroscopic method and described below. Patients with patellar, trochlear, or multiple lesions were not considered as they were beyond the current capabilities of this technique.
Therefore, over the recruitment period (June 2006 to April 2010), a total of 73 patients underwent MACI grafting (31 arthroscopic). The arthroscopic technique permits easy conversion to a mini-open technique at any stage during the operation if required. However, none of the patients who were planned for the arthroscopic method (n = 31) required conversion to an open technique during the course of the operation. A flowchart of study recruitment and assessment is provided in Figure 1 . All patients gave their written informed consent before study enrollment and preoperative evaluation, and ethics approval was obtained from the Hollywood Private Hospital (HPH145). This study conformed to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist.
MACI Surgical Technique
Arthroscopic biopsy and subsequent implantation of the matrix have been previously described, 9 with this study presenting an extension of this cohort with midterm clinical and radiological follow-ups. Briefly, arthroscopic surgery was initially performed to harvest healthy articular cartilage from the nonweightbearing trochlear notch or the medial/lateral femoral condylar ridge for cell culturing. The geometry and containment of the defect, suitability for second-stage arthroscopic implantation, and meniscal and ligamentous integrity were also assessed at this time. The biopsy specimen was then sent to a laboratory (Genzyme), whereby chondrocytes were isolated from the cartilage tissue, cultured for approximately 4 to 8 weeks, and seeded onto a type I/III collagen membrane (ACIMaix; Matricel) 3 days before second-stage reimplantation.
At second-stage arthroscopic graft implantation, standard anteromedial and anterolateral portals were employed. The joint was irrigated using Ringer lactate solution. The lesion was prepared by debriding the walls to ensure a well-defined and contained defect and removing all damaged cartilage down to the subchondral plate. The defect was then ''mapped'' in several planes using the end of a graduated arthroscopic probe, and based on these measurements, the matrix was oversized and cut. The knee was converted to ''dry'' arthroscopic surgery by draining all fluid and drying the defect bed. The graft was introduced via a large-bore arthroscopic cannula, with an 8-mm inner diameter and no valves (Conmed Linvatec), and positioned within the defect. The graft size was reassessed, and further trimming was performed if required. After the matrix size and orientation was achieved, the graft was folded away from the defect to introduce fibrin glue via a 19-gauge needle (Becton Dickinson) before repositioning of the graft. A Silastic Foley catheter (Cook Urological) was introduced and the balloon inflated with saline to distribute 30 seconds of even pressure. Visualization of the matrix was permitted via the opposite portal, with the transparent Silastic catheter allowing graft visualization underneath. The knee was put through several cycles of knee flexion and extension under visualization to ensure graft stability.
Postoperative Rehabilitation
All patients underwent a coordinated postoperative rehabilitation program of progressive exercises and graduated weightbearing over 3 months, while further education and advice were provided up until the 12-month time point (Table 1 ) and beyond if required. 14 
Clinical Evaluation
Patients were evaluated preoperatively; at 3 and 6 months; and at 1, 2, and 5 years after surgery using (1) the KOOS 51 to assess pain, symptoms, activities of daily living, sport and recreation, and knee-related quality of life; (2) the Lysholm knee scale (LKS); (3) a 0-to-10 visual analog scale (VAS) to evaluate the frequency (VAS-F) and severity (VAS-S) of knee pain; (4) the Tegner activity scale (TAS) to evaluate the patient's activity level on a scale ranging from sick leave or disability (0 points) to elite competitive (soccer) sports (10 points) 54 ; and (5) the Short Form-36 Health Survey (SF-36) mental component score (MCS) and physical component score (PCS). 4 A patient satisfaction questionnaire was employed at 5 years after surgery to investigate each patient's overall level of satisfaction, as well as their satisfaction with MACI in relieving knee pain and improving their ability to perform normal daily activities and their ability to participate in sport.
Objectively, maximal active knee flexion and extension were evaluated before surgery and at all postoperative time points as well as the 6-minute walk test 11, 48 to assess the maximum comfortable distance that the patient could walk in a 6-minute period. Isokinetic strength of the quadriceps and hamstring muscle groups was assessed at 1, 2, and 5 years after surgery using an isokinetic dynamometer (Isosport International). Concentric knee extension and flexion strength was measured through a range of 0°to 90°of knee flexion at a single isokinetic angular velocity of 90 deg/s. Each trial consisted of 4 repetitions: 3 lowintensity repetitions of knee extension and flexion, immediately followed by 1 maximal test effort. Two trials on each lower limb were performed, alternating between the operated and nonoperated limbs. During each maximal effort, patients were asked to perform with maximal muscle strength, while standardized verbal encouragement was provided. For all efforts, the peak torque value and hamstring/quadriceps (H/Q) ratio were obtained, measured by dividing the peak concentric hamstring torque by the peak concentric quadriceps torque. The limb symmetry index (LSI) was calculated for all strength measures by dividing the peak values on the operated limb by those recorded on the nonoperated limb.
Radiological Evaluation
High-resolution MRI was performed at 3 months as well as 1, 2, and 5 years after surgery using a 3-T clinical scanner (Siemens; Philips; General Electric). Standardized proton density and T2-weighted fat-saturated images were obtained in the coronal and sagittal planes (slice thickness, 3 mm; field of view, 14-15 cm; 512 matrix in at least 1 axis for proton density images with a minimum 256 matrix in 1 axis for T2-weighted images). Additional axial proton density fat-saturated images were obtained (slice thickness, 3-4 mm; field of view, 14-15 cm; minimum 224 matrix in at least 1 axis).
We sought to evaluate 8 pertinent parameters of graft repair (graft infill, signal intensity, border integration, surface contour, structure, effusion, subchondral lamina, and subchondral bone), 37 following the magnetic resonance observation of cartilage repair tissue (MOCART) scoring system. 36, 48, 58, 59 The 8 defined parameters were each scored from 1 to 4 (1 = poor; 2 = fair; 3 = good; 4 = excellent) in comparison to the adjacent native cartilage, although graft infill could also be scored with a fifth level (3.5, very good) corresponding with ''graft hypertrophy.'' 37, 58 An MRI composite score was also calculated by multiplying each individual score by a weighting factor 48 and adding the scores together. The MRI evaluation was performed by an independent, experienced musculoskeletal radiologist, who was blinded to the clinical details and clinical outcome assessment findings.
Statistical Analysis
To investigate the progression of clinical and MRI-based outcomes over time, a 1-way repeated-measures analysis of variance (ANOVA) was used. Repeated-measures ANOVAs were also used to investigate the change in strength outcomes (knee extension and flexion torque, H/Q ratio) throughout the postoperative timeline between the operated and nonoperated limbs. The number and percentage of grafts evaluated as good or excellent for each of the 8 parameters of graft repair and the MRI composite score were presented at 3 months and at 1, 2, and 5 years after surgery. The kappa coefficient was used to assess intraobserver reliability for the 8 pertinent morphological MRI scores, while the intraclass correlation coefficient (ICC) was used for the continuous MRI composite score. This was achieved by rescoring 20 randomly selected MRI scans filtered through a second time to the radiologist. Statistical analysis was performed using SPSS software (version 17.0; SPSS), while statistical significance was determined at P \ .05.
RESULTS
The 31 patients who underwent arthroscopic MACI included 25 who underwent surgery on the femoral condyles (18 medial, 7 lateral) and 6 who underwent surgery on the tibial plateau (2 medial, 4 lateral) ( Table 2 ). The mean defect size was 2.52 cm 2 (range, 1.00-5.00 cm 2 ), and the mean preoperative duration of symptoms was 7.6 years (range, 1.0-25.0 years); 18 patients (58%) had been treated previously with !1 knee surgical procedures, including arthroscopic surgery with chondral debridement with or without the removal of a loose body (n = 12), partial meniscectomy (n = 7), anterior cruciate ligament (ACL) reconstruction (n = 4), and MACI through open arthrotomy (n = 1).
Apart from 2 patients who missed their 6-month clinical evaluation (an intention-to-treat analysis was performed using the last value carried forward technique for these 2 time points) and 1 patient who was pregnant and could not undergo MRI at 5 years after surgery (and was also not evaluated clinically at 5 years), clinical and MRI evaluations in all other patients (and at all time points) were completed.
Clinical Evaluation
There was a significant improvement (P \ .05) throughout the preoperative and postoperative timeline for all patientreported outcome scores, apart from the SF-36 MCS (Table  3) . Of all 30 patients who completed the patient satisfaction questionnaire at 5 years after surgery, 93% (n = 28) were satisfied with the ability of MACI to relieve their knee pain, 90% (n = 27) were satisfied with the improvement in their ability to undertake daily activities, and 80% (n = 24) were satisfied with the improvement in their ability to participate in sport. Overall, 90% (n = 27) of patients were satisfied with the results of their MACI surgery.
Active knee range of motion (ROM; flexion and extension) and the 6-minute walk distance significantly improved (P \ .05) throughout the postoperative timeline (Table 3) . While peak knee extension torque (P = .042) and the H/Q ratio (P = .045) significantly improved over time, there was no change (P = .113) in peak knee flexion torque (Table 4 ). There were no group or interaction effects in any of the strength measures, and all knee extension and flexion LSIs were above 90% (apart from peak knee extension strength at 1 year), when comparing the operated and nonoperated limbs (Table 4) .
Radiological Evaluation
The evaluation of intraobserver reliability indicated perfect agreement for 6 of the 8 individual MRI parameters (graft infill = 1.00; signal intensity = 1.00; border integration = 0.93; surface contour = 1.00; structure = 0.92; subchondral lamina = 1.00; subchondral bone = 1.00; and effusion = 1.00), and an ICC for the MRI composite score of 0.996 (95% CI, 0.991-0.999), for the 20 randomly selected image pairs.
The MRI composite score significantly improved (P = .028) from 3 months to 5 years after surgery (Table 5) . With respect to individual parameters, significant improvement was observed over time for graft infill (P = .033), signal intensity (P \ .0001), and subchondral lamina (P \ .0001), although there were no significant time effects (P . .05) for the remaining variables (Table 5) . Of the 30 grafts evaluated with MRI at 5 years after surgery, 90% (n = 27) demonstrated good to excellent tissue infill (Table  6) , with 80% (n = 24) demonstrating either complete tissue infill or hypertrophy, in comparison to the adjacent native cartilage. Furthermore, 80% (n = 24) of grafts scored good to excellent on the MRI composite score (Table 6 ). Figure 2 shows the development of a postoperative MACI graft located on the medial femoral condyle for 1 patient, as assessed via MRI, throughout the postoperative timeline.
Complications and Failures
No early postoperative complications were observed, such as wound infections, hematomas, or deep vein thrombosis (DVT). In total, 3 (10%) patients demonstrated a hypertrophic graft at 3 months after surgery, of which 2 remained hypertrophic out to 5 years. A further 5 patients (16%) had reduced or full tissue infill at 3 months (compared with the native cartilage), although they had become hypertrophic on MRI at 12 months. In total, 7 patients (23%) exhibited hypertrophic grafts on MRI at 5 years, of which none had associated pain or mechanical symptoms. The distribution of these was the following: medial femoral condyle (n = 5), lateral femoral condyle (n = 1), and lateral tibial plateau (n = 1). One graft failure was previously reported and evident in a compliant 29-year-old male patient with a preoperative BMI of 26.0 kg/m 2 and no pre-existing conditions that would warrant surgical exclusion. 9 This patient had also failed MACI performed via open arthrotomy to the same defect location 6 years before this surgical procedure. In addition, 1 further failure was observed at 5 years after surgery in a patient who demonstrated good tissue infill at earlier postoperative time points (Figure 3 ).
DISCUSSION
While encouraging clinical outcomes have been reported for MACI, 5, 12, 18, 19, 28, 41, 53 the open arthrotomy procedure traditionally required for second-stage implantation presents a range of associated potential complications (61) 12 (39) 10 (32) 8 (26) 5 (16) 8 (26) 1 (3) 17 (55) 1 y (n = 31 grafts)
Good to excellent 28 (90) 22 (71) 21 (68) 21 (68) 26 (84) 31 (100) 21 (68) 30 (97) 24 (77) Poor to fair 3 (10) 9 (29) 10 (32) 10 (32) 5 (16) 0 (0) 10 (32) 1 (3) 7 (23) 2 y (n = 31 grafts)
Good to excellent 28 (90) 26 (84) 26 (84) 23 (74) 26 (84) 28 (90) 22 (71) 29 (94) 25 (81) Poor to fair 3 (10) 5 (16) 5 (16) 8 (26) 5 (16) 3 (10) 9 (29) 2 (6) 6 (19) 5 y (n = 30 grafts)
Good to excellent 27 (90) 26 (87) 26 (87) 21 (70) 24 (80) 27 (90) 21 (70) 29 (97) 24 (80) Poor to fair 3 (10) 4 (13) 4 (13) 9 (30) 6 (20) 3 (10) 9 (30) 1 (3) 6 (20) a Values are shown as n (%). MRI, magnetic resonance imaging. such as arthrofibrosis, decreased ROM, pain, and scarring. Therefore, a number of arthroscopic techniques have now been proposed. # We hypothesized that a significant improvement in clinical and radiological outcomes would be observed up to 5 years after arthroscopically performed MACI. In this study, significant and sustained improvement was observed in patient-reported outcome and functional measures, as well as MRI-based morphological graft scores, along with high levels of patient-reported satisfaction.
We observed significant postoperative improvement in the majority of clinical measures employed, including all KOOS subscales, the LKS, the TAS, the SF-36 PCS, reported knee pain frequency and severity, active knee flexion and extension, and 6-minute walk distance. Apart from the KOOS sport and recreation subscale and the 6-minute walk test, which fell between the preoperative and 3-month postoperative evaluations largely because of the physical limitations imposed on patients in this early postoperative period, 23, 49 all scores appeared better as early as 3 months and continued to improve throughout the postoperative timeline. While the specific use of our chosen patient-reported outcome tools could not be located in existing 5-year reports using arthroscopic MACI, it would appear that these outcomes are comparable with MACI performed through open arthrotomy at 5 years. 10, 12 Furthermore, the objective measures (knee ROM and 6-minute walk distance) are at least comparable, if not better, than these prior publications. 10, 12 We observed no significant differences between the operated and nonoperated limbs in maximal isokinetic knee strength (extension or flexion) throughout the postoperative timeline. Prior research investigating isokinetic knee strength after MACI performed via open arthrotomy demonstrated a significant peak knee extension torque deficit on the operated limb at all preoperative and postoperative time points to 5 years. 13 It may be that arthroscopic MACI permits a more accelerated rehabilitation process with reduced soft tissue trauma and pain, muscular inhibition, and associated maintenance of strength. Postoperatively, the restoration of lower limb muscle function including isokinetic knee strength is considered important for a successful return to physical activity. 1, 2, 26, 33, 55 While several LSI cutoffs have been reported in evaluating strength and functional performance with respect to ACL reconstruction, 3 both \90% 27,47,55 and \85% 38,42 have been regarded as unsatisfactory and abnormal and may suggest that a patient is unsafe to return to regular sport activity. In this study, apart from the peak knee extension LSI at 1 year after surgery (88%), all other knee extension and flexion LSIs at the remaining time points were above 90%.
Overall, the significant clinical and functional improvement throughout the postoperative timeline correlated with a high level of satisfaction reported by patients in this study. At 5 years after surgery, 93% of patients were satisfied with the ability of MACI to relieve their knee pain and 90% with the improvement in their ability to undertake daily activities. Furthermore, while specific sports were not explored, the significant postoperative improvement in the TAS as well as the sport and recreation subscale of the KOOS likely contributed to 80% of patients reporting satisfaction with the improvement in their ability to participate in sport.
The MRI composite score and graft infill significantly improved over time, with 5-year scores at least comparable with those of prior research employing an identical scoring tool in patients 5 years after MACI performed via open arthrotomy. 10, 12 On MRI, it was evident that tissue infill continued through to 2 years after surgery and maintained to 5 years. While individual parameters of structure, subchondral bone, and effusion appeared to improve to 5 years, signal intensity, border integration, surface contour, and subchondral lamina, and the combined MRI composite score, all improved to 2 years before a mild decline to 5 years after surgery. While this was not significant, it may well have been created by a graft failure reflected on MRI at 5 years in a patient who demonstrated good tissue infill at 3 months and 1 and 2 years after surgery.
At 5 years, 87% of grafts demonstrated good to excellent tissue infill in comparison to the native cartilage, with 80% demonstrating either complete tissue infill or graft hypertrophy. The MRI composite score was also rated good to excellent in 80% of grafts at 5 years. Prior research presenting the incidence of complete tissue infill at 2 to 5 years after MACI is varied, ranging from 40% to 92% of cases. 10, 12, 18, 28, 59 We observed 7 patients (23%) with graft hypertrophy on MRI at 5 years after surgery, predominantly on the medial femoral condyle. While this remains slightly higher than some reported literature at 5 years after MACI, including 12% 12 and 13%, 18 20% to 24% 10 has also been reported at 5 years, with one study also reporting graft hypertrophy in 25% of cases at 3-year follow-up. 53 Nevertheless, it should be noted that none of the 7 patients in this study with hypertrophy on MRI at 5 years were symptomatic.
We observed 7 patients with asymptomatic graft hypertrophy at 5 years after surgery, although there were 2 documented graft failures in this cohort at (or before) 5 years after surgery. One of these had been previously reported in a compliant 29-year-old male patient, with a preoperative BMI of 26.0 kg/m 2 and who had previously failed MACI performed with open arthrotomy 6 years prior. 9 Despite encouraging tissue repair at 3 months and 1 and 2 years after surgery, a second failure developed as defined on MRI at 5 years. We were unable to ascertain any reason for this failed case. While it has been reported that graft delamination generally presents within the first 6 months, 39 these failures were documented on MRI at 1 and 5 years for the first and second case, respectively. Prior 5-year follow-up studies after MACI have reported failure rates of 3%, 12 5%, 28 and 9%, 10 with a 2-to 7-year follow-up also documenting 7%. 41 While 5-year clinical and MRI-based scores in this study appear comparable (or better) than those reported for MACI previously, 10 20 reported a lack of evidence for any superiority of MACI over first-generation (periostealcovered) or second-generation (collagen-covered) chondrocyte implantation techniques, although they also stated that these findings were limited by a short duration of follow-up, small and younger patient cohorts, and the evaluation of medium-sized defects. Samsudin and Kamarul 52 reiterated these findings in their review reporting no superiority and a trend toward similar outcomes when comparing autologous chondrocyte implantation (ACI) generations with other cartilage repair techniques. However, they reported similar limitations in synthesizing the literature, also stating issues such as heterogeneous patient demographics, interventions, and outcomes employed.
The role of microfracture in treating cartilage defects was reviewed by Goyal et al, 22 and while they reported it to be of benefit for small lesions in patients with low postoperative demands at short-term follow-up, failure could be expected beyond 5 years regardless of the lesion size. Oussedik et al 45 reported the benefit of MACI over microfracture in their review. In this current study, we showed that clinical outcomes, MRI-based graft status, and patient satisfaction all remained stable at 5 years, although longer term follow-up will continue with time. The benefits of MACI over osteochondral autograft transfer (OAT) techniques remain less clear, and while a recent review demonstrated the superiority of OAT over microfracture, 21 of the 4 studies that were included comparing OAT and periosteal and/or collagen-covered ACI, no difference could be demonstrated. However, there have been no studies comparing MACI with osteochondral grafting methods. Finally, based on the studies included in a recent review comparing marrow stimulation, ACI, and OAT techniques, 40 no significant difference in pain and functional improvement could be demonstrated at intermediateterm follow-up. Again, a sound comparison of techniques remains limited by the lack of a long-term comparative follow-up and heterogeneity in the clinical and MRI-based outcome measures employed.
We acknowledge some limitations in this study. First, this prospective case series lacks any comparative cohort, although the 31 patients presented reflect the first 31 who were planned for, and subsequently underwent, this arthroscopic MACI procedure. Therefore, the noncomparative design was reflective of the pilot nature of such a surgical technique, to investigate the safety, efficacy, and outcomes compared with existing published MACI research, before embarking on comparative studies of arthroscopic and mini-open techniques of MACI. Second, we acknowledge that because of the noncomparative nature of this pilot study, employing only a single preoperative patient clinical evaluation, there is always uncertainty in exactly how much of the observed clinical effect is attributable to the treatment, even given the encouraging MRI outcomes and apparent regeneration of tissue.
Third, evolving MRI evaluation methods investigating the biochemical characteristics of the repair tissue are emerging, including dGEMRIC (delayed gadoliniumenhanced MRI of cartilage) and T2 mapping. 31, 56, 57 These may provide more information on the ''ultrastructure'' of the repair tissue 8 compared with the morphological graft scoring system that we have employed. Finally, we chose to employ patient-reported outcome measures (KOOS, SF-36, VAS) used routinely for chondrocyte implantation 4, 11, 36, 44, 48 although a specific cartilage repair outcome measure is currently lacking. 24 Furthermore, a number of other clinical scoring tools do exist and have been used in other research, which may make a comparison of outcomes among these studies difficult.
It has been stated that an arthroscopic implantation technique may minimize adhesions, pain, and scarring, as well as improve active knee ROM, while accelerating postoperative rehabilitation because of reduced pain and muscular deficits. 16 This arthroscopically performed MACI technique demonstrated good clinical and radiological outcomes up to 5 years, with high levels of patient satisfaction. This current research supports prior published work suggesting that MACI does provide a suitable midterm treatment option for articular cartilage defects in the knee. Long-term follow-up of these patients will continue to confirm the durability of repair tissue and the longevity of improved patient clinical outcomes and quality of life, while future research should look to compare different techniques (arthroscopic and open) to investigate whether less invasive methods reduce the morbidity of arthrotomy and permit accelerated rehabilitation.
